Thyroid Function of Pediatric Subjects Following Isovue® Administration
Status:
Recruiting
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
This is a Phase IV prospective, multicenter, observational study to estimate the proportion
of subjects 0 to 3 years of age who develop abnormal thyroid function after exposure to
intravascular administration of ISOVUE for the required radiologic procedure as part of their
standard of care.